AlphaStocks
5.5
Consider Buy

Integra Lifesciences Holdings Corp (IART)

As of Sep 20, 2026, Integra Lifesciences Holdings Corp (IART) scores 5.5/10 on AlphaStocks' five-model composite, #74 of 168 Health Care stocks. At $15, IART trades 37% below its model fair value of $24.

Health Care / Health Care Equipment

S&P SmallCap 600

$15.22

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#74out of 168 in Health Care

Is INTEGRA LIFESCIENCES HOLDINGS CORP a Good Investment in 2026?

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) scores 5.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates INTEGRA LIFESCIENCES HOLDINGS CORP as Attractive (5/9). However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -30.2% · ROC -51%. INTEGRA LIFESCIENCES HOLDINGS CORP currently trades 37% below its estimated fair value of $24. INTEGRA LIFESCIENCES HOLDINGS CORP ranks #74 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-38.7Market Cap1B

Estimated Fair Value

$24.0237% below

Trading below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield -30.2% · ROC -51%

Frequently Asked Questions

Is INTEGRA LIFESCIENCES HOLDINGS CORP (IART) a good investment?
As of Sep 20, 2026, Integra Lifesciences Holdings Corp (IART) scores 5.5/10 on AlphaStocks' five-model composite, #74 of 168 Health Care stocks. At $15, IART trades 37% below its model fair value of $24. That is a middle-of-the-pack score with no strong signal either way.
What is INTEGRA LIFESCIENCES HOLDINGS CORP's Piotroski F-Score?
INTEGRA LIFESCIENCES HOLDINGS CORP's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is IART overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $24, IART appears undervalued. The stock currently trades 37% below its estimated fair value. Trading below estimated fair value.
How does IART compare to other Health Care stocks?
INTEGRA LIFESCIENCES HOLDINGS CORP ranks #74 out of 168 stocks in the Health Care sector, placing it in the top 44% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about IART?
AlphaStocks evaluates IART using five proven investment models. Piotroski: Attractive; Buffett: Caution; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.5/10.

Similar Stocks

INSPUFPTBDX

Compare IART with

IART vs INSPIART vs UFPTBDX vs IART

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer